AT Systemisation is a company that has issued a large number of new shares recently which has caused its share price to rapidly increase, even though it has not yet produced any medical gloves and has reported losses over the past 7 quarters. The company placed out 30 million new shares at 17 sen per share on November 27th and in February issued 998 million new shares at 3.5 sen per share along with free warrants. It also allows employees to buy 328 million new shares, significantly increasing the total number of issued shares to over 3 billion. While the new publicity has driven investment, investors should be aware of the company's lack of revenues or profits from its planned glove production.
AT Systemisation is a company that has issued a large number of new shares recently which has caused its share price to rapidly increase, even though it has not yet produced any medical gloves and has reported losses over the past 7 quarters. The company placed out 30 million new shares at 17 sen per share on November 27th and in February issued 998 million new shares at 3.5 sen per share along with free warrants. It also allows employees to buy 328 million new shares, significantly increasing the total number of issued shares to over 3 billion. While the new publicity has driven investment, investors should be aware of the company's lack of revenues or profits from its planned glove production.
AT Systemisation is a company that has issued a large number of new shares recently which has caused its share price to rapidly increase, even though it has not yet produced any medical gloves and has reported losses over the past 7 quarters. The company placed out 30 million new shares at 17 sen per share on November 27th and in February issued 998 million new shares at 3.5 sen per share along with free warrants. It also allows employees to buy 328 million new shares, significantly increasing the total number of issued shares to over 3 billion. While the new publicity has driven investment, investors should be aware of the company's lack of revenues or profits from its planned glove production.
About 2 weeks ago, Mr Mak, executive director came to my house to take me to visit his glove factory in Chemor, Perak. He also invited many other investors and reporters. This has created a lot of publicity. As a result, many investors rushed to buy ATS share aggressively to push up the share price. I was misled to buy some shares and I post 2 buy recommendation articles. As soon as I found out my mistake, I posted my article to forewarn investors. After careful research, I found out the following which all investors should know. Its total number of issued shares is 3,282 million On 27 Nov, the company placed out 30 million shares at 17 sen per share. On 27 February, the company issued 998 million shares at 3.5 sen per share and 748 million free convertible warrants to the shareholder. For every 4 shares held by a shareholder, he was entitled to buy 2 right issues at 3.5 sen per share with 3 free warrants which can be converted within 5 years and the conversion price is 3.5 sen per share. In addition, under ESSO all employees are entitled to buy 328 million shares at 3.5 sen per share. The company has not produced 1 medical glove. Moreover, the company has reported losses in every quarter in the last 7 quarters.